Actively Recruiting
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Led by Medical University Innsbruck · Updated on 2025-12-02
800
Participants Needed
1
Research Sites
254 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
CONDITIONS
Official Title
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
- Residence in Austria
- Signed and dated patient consent following ICH-GCP guidelines
You will not qualify if you...
- Pregnancy
- Age below 18 years
- Contraindications to study-related routine exams such as inability to draw blood due to needle phobia or no CT scan possible due to claustrophobia or pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University Innsbruck
Innsbruck, Austria, Austria, 6020
Actively Recruiting
Research Team
T
Thomas Sonnweber, MD, PhD
CONTACT
D
David Haschka, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here